Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 13882
Country/Region: Kenya
Year: 2016
Main Partner: Children of God Relief Fund
Main Partner Program: NA
Organizational Type: FBO
Funding Agency: USAID
Total Funding: $1,647,637 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $11,317
Care: Orphans and Vulnerable Children (HKID) $595,562
Care: TB/HIV (HVTB) $19,588
Care: Pediatric Care and Support (PDCS) $461,810
Testing: HIV Testing and Counseling (HVCT) $16,792
Treatment: Adult Treatment (HTXS) $328,639
Treatment: Pediatric Treatment (PDTX) $213,929
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Age/sex: <1 2017 165
HTS_TST Age/sex: 1-9 2017 411
HTS_TST Age/sex: 10-14 Female 2017 272
HTS_TST Age/sex: 10-14 Male 2017 251
HTS_TST Age/sex: 15-19 Female 2017 387
HTS_TST Age/sex: 15-19 Male 2017 363
HTS_TST Age/sex: 20-24 Female 2017 905
HTS_TST Age/sex: 20-24 Male 2017 844
HTS_TST Age/sex: 25-49 Female 2017 940
HTS_TST Age/sex: 25-49 Male 2017 839
HTS_TST Age/sex: 50+ Female 2017 94
HTS_TST Age/sex: 50+ Male 2017 93
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 693
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 692
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 2,321
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 2,137
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 5,843
HTS_TST Service Delivery Point (Facility): VCT 2017 5,843
HTS_TST Sum of Age/Sex disaggregates 2017 4,988
HTS_TST Sum of Aggregated Age/Sex <15 2017 1,385
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 4,458
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 5,843
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 82
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 77
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 40
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 36
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 45
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 44
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 30
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 29
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 10
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 9
HTS_TST_POS Test Result by Age: Positive: <1 2017 30
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 88
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 175
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 156
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 128
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 117
OVC_SERV Age/Sex: 18+ Female 2017 1,829
OVC_SERV Age/Sex: 18+ Male 2017 1,229
OVC_SERV By Aggregated Age/Sex: <18 Female 2017 5,800
OVC_SERV By Aggregated Age/Sex: <18 Male 2017 4,728
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2017 13,586
OVC_SERV Sum of Age/Sex disaggregates 2017 3,058
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 40
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 61
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 26
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 8
PMTCT_EID Sum of Infant Age disaggregates 2017 101
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 12
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 3
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 10
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 1
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 26
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 26
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 37
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 1
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 36
TB_SCREENDX Screen Result: Screened Positive for TB 2017 39
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 594
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 539
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 1,134
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 1,120
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 3,387
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 29
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 12
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 26
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 9
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 76
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 76
TX_CURR Age/Sex: <1 2017 96
TX_CURR Age/Sex: <1-9 2017 879
TX_CURR Age/Sex: 10-14 Female 2017 607
TX_CURR Age/Sex: 10-14 Male 2017 595
TX_CURR Age/Sex: 15-19 Female 2017 473
TX_CURR Age/Sex: 15-19 Male 2017 441
TX_CURR Age/Sex: 20-24 Female 2017 96
TX_CURR Age/Sex: 20-24 Male 2017 93
TX_CURR Aggregated Age/Sex: <15 Female 2017 1,134
TX_CURR Aggregated Age/Sex: <15 Male 2017 1,120
TX_CURR Aggregated Age/Sex: 15+ Female 2017 594
TX_CURR Aggregated Age/Sex: 15+ Male 2017 539
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 3,387
TX_CURR Sum of age/sex disaggregates 2017 914
TX_CURR Sum of Aggregated Age/Sex <15 2017 2,254
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 1,133
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 3,387
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 149
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 136
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 38
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 37
TX_NEW By Age/Sex: <1 2017 11
TX_NEW By Age/Sex: 1-9 2017 116
TX_NEW By Age/Sex: 10-14 Female 2017 82
TX_NEW By Age/Sex: 10-14 Male 2017 73
TX_NEW By Age/Sex: 15-19 Female 2017 37
TX_NEW By Age/Sex: 15-19 Male 2017 40
TX_NEW By Age/Sex: 20-24 Female 2017 1
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 360
TX_NEW Sum of Age/Sex disaggregates 2017 233
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 360
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 3,383
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 3,048
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 1,048
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 1,021
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 512
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 467
TX_PVLS Numerator: Indication: Targeted 2017 3,048
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 1,144
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 1,124
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 582
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 533
TX_PVLS_den Denominator: Indication: Targeted 2017 3,383
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 10
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 94
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 71
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 69
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 41
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 33
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 120
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 115
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 45
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 44
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 324
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 329
TX_RET_den Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 10
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 94
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 71
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 69
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 44
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 34
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 4
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 3
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 121
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 114
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 47
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 47